earnings
OR
NASDAQ · ORGO
Organogenesis Holdings Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$1.39
Down-$0.07 (-4.79%)
Updated Sep 17, 2026, 1:05 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 607.66M
- P/E ratio
- -69.15
- Dividend yield
- 0.00%
- 52-week range
- $1.45 – $2.82
- Volume
- 943.81K
- Avg. volume
- 1.55M
Price performance
ORGO price history
1M range · 20 trading sessions · Daily adjusted prices
ORGO closed at $1.39 after 20 trading sessions, down 27.23% for the selected period.
- Last close
- $1.39
- Period change
- -27.23%
- Period low
- $1.39
- Period high
- $1.91
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.45 | $1.465 | $1.38 | $1.39 | 943.81K |
| Sep 15, 2026 | $1.49 | $1.495 | $1.45 | $1.46 | 445.07K |
| Sep 14, 2026 | $1.49 | $1.51 | $1.45 | $1.50 | 646.88K |
| Sep 11, 2026 | $1.56 | $1.56 | $1.47 | $1.49 | 844.15K |
| Sep 10, 2026 | $1.57 | $1.57 | $1.49 | $1.53 | 912.47K |
| Sep 9, 2026 | $1.58 | $1.59 | $1.55 | $1.57 | 465.74K |
| Sep 8, 2026 | $1.68 | $1.68 | $1.57 | $1.60 | 979.73K |
| Sep 4, 2026 | $1.65 | $1.73 | $1.625 | $1.71 | 665.54K |
| Sep 3, 2026 | $1.69 | $1.695 | $1.59 | $1.64 | 561.48K |
| Sep 2, 2026 | $1.63 | $1.72 | $1.63 | $1.67 | 991.05K |
| Sep 1, 2026 | $1.70 | $1.71 | $1.62 | $1.63 | 1.06M |
| Aug 31, 2026 | $1.74 | $1.75 | $1.665 | $1.72 | 638.4K |
| Aug 28, 2026 | $1.73 | $1.75 | $1.70 | $1.74 | 358.93K |
| Aug 27, 2026 | $1.76 | $1.76 | $1.70 | $1.74 | 526.14K |
| Aug 26, 2026 | $1.74 | $1.75 | $1.685 | $1.75 | 376.71K |
| Aug 25, 2026 | $1.68 | $1.755 | $1.68 | $1.74 | 679.2K |
| Aug 24, 2026 | $1.81 | $1.81 | $1.66 | $1.67 | 792.63K |
| Aug 21, 2026 | $1.84 | $1.87 | $1.78 | $1.80 | 563.53K |
| Aug 20, 2026 | $1.88 | $1.92 | $1.83 | $1.84 | 732.82K |
| Aug 19, 2026 | $1.80 | $1.95 | $1.80 | $1.91 | 604.77K |
Latest ORGO news
The latest Smart Investors Daily articles mentioning ORGO.
Stock researchResearch & News · Competitors
Loading stock research…